Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
Details for Australian Patent Application No. 2004266126 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/018540 Priority application(s): WO2005/018540
15 June 2006 Assignment before Grant
Dufour, Jannette; Halberstadt, Craig; Hemendinger, Richelle; Rajotte, Ray V.; Vasconcellos, Alfred V.; Gores, Paul; Emerich, Dwaine; Korbutt, Greg The application has been assigned to Sertoli Technologies, Inc.
9 June 2011 Application Accepted
Published as AU-B-2004266126
28 July 2011 Corrigenda
Applications Accepted - Name Index Under the name Sertoli Technologies, Inc., Application No. 2004266126, under INID (71) correct the applicant name to Sertoli Technologies, LLC
6 October 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004266127-(20S)-1alpha-hydroxy-2-methylene-19nor-vitamin D3 and its uses
2004266122-Technique and instrumentation for preparation of vertebral members
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser